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OBITUARIES 
Peter Jacobs
Dr Peter Jacobs was a pioneer of clinical 
and laboratory haematology in South 
Africa (SA). Although much of his career 
coincided with years of apartheid-related 
isolation, his enormous influence was felt 
internationally. He led the Department of 
Haematology at the University of Cape 
Town and later served as head of Clinical 
Haematology at Stellenbosch University. 
In the early 1970s, at a time when Cape 
Town was central to the field of organ 
transplantation, Jacobs’ major achievement 
was the introduction of experimental and 
clinical bone marrow transplantation 
(BMT). He published the seminal report of 
hepatic veno-occlusive disease after BMT in 
the SAMJ.[1] With colleagues at Cambridge 
University he developed techniques to 
reduce graft-versus-host disease through ex 
vivo application of the monoclonal antibody 
Campath 1G. He was also instrumental 
in the establishment of the South African 
Bone Marrow Registry. In recognition of his 
outstanding academic accomplishments, he 
was awarded the centenary medal by the 
South African Academy of Arts and Science 
in 2009.
Throughout his career, Jacobs trained and 
mentored countless medical students, nurses, 
laboratory technicians, graduate physicians 
and basic scientists. In the midst of political 
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and economic instability in SA, many of 
his trainees left the country to develop 
their academic careers worldwide. Jacobs 
remained in SA and continued to practise 
academic medicine with a tireless, systematic 
and inquisitive approach. His longstanding 
interest in lymphoma was influenced in 
recent years by the region’s HIV epidemic. 
Jacobs’ biennial South African Lymphoma 
Study Group conferences, initiated in 1982, 
were regularly attended by local and visiting 
lymphoma experts of international repute. 
The fifteenth of such meetings was held in 
2012, where Jacobs’ closing remark was to 
eagerly invite the attendees to return to Cape 
Town in 2014. Despite his absence, they will 
very likely do so.
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